Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

ClinicalTrials.gov ID: NCT02879305

Public ClinicalTrials.gov record NCT02879305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 11:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin, Following a Switch From Erythropoietin-stimulating Agents

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy of daprodustat.

Study identification

NCT ID
NCT02879305
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
2,964 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2016 (Actual)
Primary completion
Nov 9, 2020 (Actual)
Completion
Nov 9, 2020 (Actual)
Last update posted
Dec 3, 2021

2016 – 2020

United States locations

U.S. sites
126
U.S. states
32
U.S. cities
106
Facility City State ZIP Site status
GSK Investigational Site Huntsville Alabama 35805 —
GSK Investigational Site Pine Bluff Arkansas 71603 —
GSK Investigational Site Anaheim California 92801 —
GSK Investigational Site Bakersfield California 93308 —
GSK Investigational Site Bakersfield California 93309 —
GSK Investigational Site Beverly Hills California 90211 —
GSK Investigational Site Cerritos California 90703 —
GSK Investigational Site Chula Vista California 91910 —
GSK Investigational Site El Centro California 92243 —
GSK Investigational Site Escondido California 92025 —
GSK Investigational Site Fairfield California 94534 —
GSK Investigational Site Fountain Valley California 92708 —
GSK Investigational Site Glendale California 91205 —
GSK Investigational Site Granada Hills California 91344 —
GSK Investigational Site Hacienda Heights California 91745 —
GSK Investigational Site La Mesa California 91942 —
GSK Investigational Site La Palma California 90623 —
GSK Investigational Site Lakewood California 90712 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Long Beach California 90807 —
GSK Investigational Site Long Beach California 90813 —
GSK Investigational Site Los Angeles California 90022 —
GSK Investigational Site Los Angeles California 90095 —
GSK Investigational Site Lynwood California 60262 —
GSK Investigational Site Montebello California 90640 —
GSK Investigational Site Monterey Park California 91754 —
GSK Investigational Site Moreno Valley California 92553 —
GSK Investigational Site Norco California 92860 —
GSK Investigational Site Northridge California 91324 —
GSK Investigational Site Ontario California 91762 —
GSK Investigational Site Riverside California 92501 —
GSK Investigational Site Sacramento California 95825 —
GSK Investigational Site San Diego California 92103 —
GSK Investigational Site San Diego California 92111 —
GSK Investigational Site San Luis Obispo California 93405 —
GSK Investigational Site Santa Clarita California 91387 —
GSK Investigational Site Simi Valley California 93065-091 —
GSK Investigational Site Tarzana California 91356 —
GSK Investigational Site Whittier California 90602 —
GSK Investigational Site Whittier California 90603 —
GSK Investigational Site Yorba Linda California 92886 —
GSK Investigational Site Middlebury Connecticut 06762 —
GSK Investigational Site Washington D.C. District of Columbia 20037 —
GSK Investigational Site Aventura Florida 33180 —
GSK Investigational Site Coral Gables Florida 33134 —
GSK Investigational Site Hollywood Florida 33024 —
GSK Investigational Site Jacksonville Florida 32224 —
GSK Investigational Site Lauderdale Lakes Florida 33313 —
GSK Investigational Site Miami Florida 33126 —
GSK Investigational Site Miami Florida 33143 —
GSK Investigational Site Miami Florida 33150 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site Miami Gardens Florida 33169 —
GSK Investigational Site Ocala Florida 34471 —
GSK Investigational Site Port Charlotte Florida 33952 —
GSK Investigational Site Spring Hill Florida 34608 —
GSK Investigational Site Winter Park Florida 32789 —
GSK Investigational Site Augusta Georgia 30904 —
GSK Investigational Site Augusta Georgia 30912 —
GSK Investigational Site Columbus Georgia 31904 —
GSK Investigational Site Meridian Idaho 83642 —
GSK Investigational Site Crystal Lake Illinois 60014 —
GSK Investigational Site Fort Wayne Indiana 46804 —
GSK Investigational Site Jeffersonville Indiana 47130 —
GSK Investigational Site Merrillville Indiana 46410 —
GSK Investigational Site Michigan City Indiana 46360 —
GSK Investigational Site Iowa City Iowa 52242 —
GSK Investigational Site Louisville Kentucky 40202 —
GSK Investigational Site Baton Rouge Louisiana 70808 —
GSK Investigational Site Baton Rouge Louisiana 70836 —
GSK Investigational Site Greenbelt Maryland 20770 —
GSK Investigational Site Takoma Park Maryland 20912-6385 —
GSK Investigational Site Kalamazoo Michigan 49007 —
GSK Investigational Site Pontiac Michigan 48341 —
GSK Investigational Site Roseville Michigan 48066 —
GSK Investigational Site Gulfport Mississippi 39501 —
GSK Investigational Site Tupelo Mississippi 38801 —
GSK Investigational Site Florissant Missouri 63033 —
GSK Investigational Site Kansas City Missouri 64111 —
GSK Investigational Site St Louis Missouri 63110 —
GSK Investigational Site Las Vegas Nevada 89102 —
GSK Investigational Site Las Vegas Nevada 89107 —
GSK Investigational Site Portsmouth New Hampshire 3801 —
GSK Investigational Site Gallup New Mexico 87301 —
GSK Investigational Site Brooklyn New York 11203 —
GSK Investigational Site Buffalo New York 14215 —
GSK Investigational Site Flushing New York 11355 —
GSK Investigational Site Mineola New York 11501 —
GSK Investigational Site New York New York 10029 —
GSK Investigational Site Ridgewood New York 11385 —
GSK Investigational Site The Bronx New York 10461 —
GSK Investigational Site Yonkers New York 10710 —
GSK Investigational Site Asheville North Carolina 28801 —
GSK Investigational Site Clyde North Carolina 28721 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Winston-Salem North Carolina 27103 —
GSK Investigational Site Winston-Salem North Carolina 27517 —
GSK Investigational Site Canton Ohio 44718 —
GSK Investigational Site Cincinnati Ohio 45206 —
GSK Investigational Site Cincinnati Ohio 45220 —
GSK Investigational Site Roseburg Oregon 97471 —
GSK Investigational Site Bethlehem Pennsylvania 18017 —
GSK Investigational Site Philadelphia Pennsylvania 19140 —
GSK Investigational Site Providence Rhode Island 02903 —
GSK Investigational Site Anderson South Carolina 29621 —
GSK Investigational Site Charleston South Carolina 29425 —
GSK Investigational Site Sumter South Carolina 29150 —
GSK Investigational Site Cordova Tennessee 38018 —
GSK Investigational Site Knoxville Tennessee 37923 —
GSK Investigational Site Knoxville Tennessee 37924 —
GSK Investigational Site Nashville Tennessee 37205 —
GSK Investigational Site Beaumont Texas 77701 —
GSK Investigational Site Houston Texas 77004 —
GSK Investigational Site Houston Texas 77030 —
GSK Investigational Site Houston Texas 77099 —
GSK Investigational Site Lufkin Texas 75904 —
GSK Investigational Site San Antonio Texas 78207 —
GSK Investigational Site San Antonio Texas 78221 —
GSK Investigational Site San Antonio Texas 78251 —
GSK Investigational Site San Antonio Texas 78258 —
GSK Investigational Site Alexandria Virginia 22304 —
GSK Investigational Site Fairfax Virginia 22033 —
GSK Investigational Site Hampton Virginia 23666 —
GSK Investigational Site Salem Virginia 24153 —
GSK Investigational Site Bluefield West Virginia 24701 —
GSK Investigational Site Shorewood Wisconsin 53211 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 336 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02879305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02879305 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →